Panacea Biotec Limited
PANACEABIO

Panacea Biotec Limited

Pharmaceuticals
Share price
₹336
Market cap
₹2,060 Cr
1Y return
▼ 6%

A research-based biotechnology company, Panacea Biotec develops and manufactures pharmaceutical products and vaccines across multiple therapeutic areas including immunology, oncology, and infectious diseases. Incorporated in 1984, the company operates through integrated manufacturing facilities and maintains a strong focus on developing affordable healthcare solutions for emerging markets. Its distinctive strength lies in combining advanced biotechnology research capabilities with specialized vaccine production expertise and a commitment to accessible medicine.

Investors holding Panacea Biotec Limited

Amal Parikh
Amal Parikh
Investor
1.47%

Recent moves 2

Massachusetts Institute Of TechnologyIncreased
Massachusetts Institute Of Technology increased its stake in Panacea Biotec Limited from 1.71% to 1.81%, purchasing 60,000 shares.
15 Oct 2026
Read more
Massachusetts Institute Of TechnologyIncreased
Massachusetts Institute Of Technology increased its stake in Panacea Biotec from 1.12% to 1.71%, raising its shareholding from 6,85,000 to 10,50,000 shares.
23 Jul 2026
Read more

Track the whales in Panacea Biotec Limited

Get alerted the moment a top investor buys or sells.

Start 7 days for ₹1